stockrowGuardant Health, Inc.
GH Healthcare Diagnostics & Research
Guardant Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $982.0 million, up 32.9% from fiscal 2024.
- Revenue
- +36.1%
- EPS
- −25.7%
- Free cash flow
- +18.7%
- Total debt
- +34.8%
Quarter to September 2026, against a year earlier
Follow GH
Alert me
Guardant Health, Inc. (GH) Return on assets
Guardant Health, Inc.'s return on assets over the twelve months to 30 September 2026 was −30.7%, down 6.9 percentage points from fiscal 2025 (−23.8%). Over the past ten years it has ranged from −51.9% (fiscal 2017) to −9.76% (fiscal 2019); the current reading is higher than 60% of that period. That is below the Diagnostics & Research industry median of −6.05% and in line with the Healthcare sector median of −29.3%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2025 | −23.8% | 2.88 |
| FY2024 | −26.7% | 1.56 |
| FY2023 | −28.2% | 6.09 |
| FY2022 | −34.3% | (16.19) |
| FY2021 | −18.1% | (2.44) |
| FY2020 | −15.7% | (5.93) |
| FY2019 | −9.76% | 8.53 |
| FY2018 | −18.3% | 33.61 |
| FY2017 | −51.9% | (25.00) |
| FY2016 | −26.9% | — |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| MTD Mettler-Toledo International, Inc. compare | 25.6% |
| MEDP Medpace Holdings, Inc. compare | 25.5% |
| ILMN Illumina, Inc. compare | 13.8% |
| DGX Quest Diagnostics Incorporated compare | 6.73% |
| LH Labcorp Holdings Inc. compare | 5.40% |
| ICLR ICON PLC compare | 2.74% |
| RVTY Revvity Inc. compare | 2.14% |
| CRL Charles River Laboratories International, Inc. compare | 0.54% |
| GH Guardant Health, Inc. | −30.7% |
| Diagnostics & Research industry median | −6.05% |
| Healthcare sector median | −29.3% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on GH
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement